Prime Therapeutics offers innovative medication management solutions, supports patients with chronic conditions

As the efficacy and cost of these therapies become clear, so is the need for thoughtful managed care strategies, according to Prime Therapeutics thought leaders

New report highlights value-based contract solution and analysis of top 10 drug classes impacting Medicaid pharmacy net trend

Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) new to Faricimab-svoa Therapy.”

Cover AMCP Prime Therapeutics /amcp-nexus-2024-research-posters 10 research posters presented by Prime at AMCP Nexus 2024 covers topics like GLP-1 obesity research, health equity initiatives, and...

A strategic deep dive into the latest trend report from Prime Therapeutics reveals how oncology spend is evolving across benefits and what it means for cancer care management

Cover image for 8 research posters presented by Prime at the 2024 AMCP Annual Meeting 2024 AMCP Annual Meeting Prime Therapeutics /2024-amcp-annual-meeting-research-posters 8 research posters...

Constant communication across the supply chain limits disruption when a drug is unavailable

Cover image for Drug Approvals Monthly Update: September 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty...

Cover image for Drug Approvals Monthly Update: August 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty...

This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process.

This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process.

Drug Approvals Quarterly Update: July 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process. Prime...

Prime’s Special Investigations Unit is specially trained to protect patients and providers throughout the health care continuum

Jessica Johnson, clinical consultant at Prime Therapeutics, shares some ways to avoid common fraud schemes

References 1. U.S. Food and Drug Administration. Application number 761381: Opdivo Qvantig (nivolumab and hyaluronidase-nvhy). Drugs@FDA. Accessed February 6, 2026....

Cover image for FDA Decisions Expected_February 2025 Drug pipeline for February 2025 Prime Therapeutics /fda-decisions-expected-february-2025 About Prime Therapeutics Prime Therapeutics logo Prime...

Event features Pat Gleason, AVP, health outcomes at Prime Therapeutics

Cover image for FDA Decisions Expected: November 2024 Drug pipeline for November 2024 Prime Therapeutics /fda-decisions-expected-november-2024 Prime Therapeutics’ FDA Decisions Expected outlines...